Olema Oncology to Participate in Upcoming Investor Conferences
Olema Pharmaceuticals (Nasdaq: OLMA), a clinical-stage biopharmaceutical company specializing in targeted therapies for breast cancer, has announced its participation in two upcoming investor conferences. The company will present at the Jefferies Global Healthcare Conference on June 4, 2025, at 11:40 a.m. ET in New York, and the Goldman Sachs 46th Annual Global Healthcare Conference on June 11, 2025, at 8 a.m. ET in Miami. Both presentations will be in a fireside chat format. Live webcasts and recordings will be accessible through Olema's investor relations website at ir.olema.com.
Olema Pharmaceuticals (Nasdaq: OLMA), un'azienda biofarmaceutica in fase clinica specializzata in terapie mirate per il cancro al seno, ha annunciato la sua partecipazione a due prossimi convegni per investitori. L'azienda presenterà al Jefferies Global Healthcare Conference il 4 giugno 2025 alle 11:40 ET a New York, e al Goldman Sachs 46th Annual Global Healthcare Conference l'11 giugno 2025 alle 8:00 ET a Miami. Entrambe le presentazioni avranno un formato di conversazione informale. Le dirette web e le registrazioni saranno disponibili sul sito delle relazioni con gli investitori di Olema all'indirizzo ir.olema.com.
Olema Pharmaceuticals (Nasdaq: OLMA), una empresa biofarmacéutica en etapa clínica especializada en terapias dirigidas para el cáncer de mama, ha anunciado su participación en dos próximas conferencias para inversores. La compañía presentará en la Jefferies Global Healthcare Conference el 4 de junio de 2025 a las 11:40 a.m. ET en Nueva York, y en la Goldman Sachs 46th Annual Global Healthcare Conference el 11 de junio de 2025 a las 8 a.m. ET en Miami. Ambas presentaciones serán en formato de charla junto a la chimenea. Las transmisiones en vivo y grabaciones estarán disponibles a través del sitio web de relaciones con inversores de Olema en ir.olema.com.
Olema Pharmaceuticals(나스닥: OLMA)는 유방암을 위한 표적 치료제를 전문으로 하는 임상 단계의 바이오제약 회사로, 다가오는 두 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 회사는 2025년 6월 4일 오전 11시 40분(동부 시간)에 뉴욕에서 열리는 Jefferies Global Healthcare Conference와 2025년 6월 11일 오전 8시(동부 시간)에 마이애미에서 열리는 Goldman Sachs 46th Annual Global Healthcare Conference에서 발표할 예정입니다. 두 발표 모두 대화 형식으로 진행됩니다. 생중계와 녹화 영상은 Olema의 투자자 관계 웹사이트 ir.olema.com에서 시청할 수 있습니다.
Olema Pharmaceuticals (Nasdaq : OLMA), une société biopharmaceutique en phase clinique spécialisée dans les thérapies ciblées contre le cancer du sein, a annoncé sa participation à deux prochaines conférences pour investisseurs. La société présentera lors de la Jefferies Global Healthcare Conference le 4 juin 2025 à 11h40 ET à New York, ainsi que lors de la Goldman Sachs 46th Annual Global Healthcare Conference le 11 juin 2025 à 8h00 ET à Miami. Les deux présentations se dérouleront sous forme de discussion informelle. Les webcasts en direct et les enregistrements seront accessibles via le site des relations investisseurs d’Olema à l’adresse ir.olema.com.
Olema Pharmaceuticals (Nasdaq: OLMA), ein biopharmazeutisches Unternehmen in der klinischen Entwicklungsphase, das sich auf zielgerichtete Therapien gegen Brustkrebs spezialisiert hat, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird am Jefferies Global Healthcare Conference am 4. Juni 2025 um 11:40 Uhr ET in New York sowie am Goldman Sachs 46th Annual Global Healthcare Conference am 11. Juni 2025 um 8 Uhr ET in Miami präsentieren. Beide Präsentationen finden im Format eines Gesprächs am Kamin statt. Live-Webcasts und Aufzeichnungen sind über die Investor-Relations-Website von Olema unter ir.olema.com zugänglich.
- None.
- None.
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following upcoming investor conferences:
Jefferies Global Healthcare Conference
Date and Time: Wednesday, June 4, 2025 at 11:40 a.m. ET
Format: Fireside Chat
Location: New York, NY
Goldman Sachs 46th Annual Global Healthcare Conference
Date and Time: Wednesday, June 11, 2025 at 8 a.m. ET
Format: Fireside Chat
Location: Miami, FL
Live webcasts and recordings of these presentations will be available, as permitted by the event host, in the Events and Presentations section of Olema’s investor relations website at ir.olema.com.
About Olema Oncology
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. Olema is advancing a pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Our lead product candidate, palazestrant (OP-1250), is a proprietary, orally available complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD), currently in a Phase 3 clinical trial called OPERA-01. In addition, Olema is developing a potent KAT6 inhibitor (OP-3136). Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts. For more information, please visit us at www.olema.com.
Media and Investor Relations Contact
Courtney O’Konek
Vice President, Corporate Communications
Olema Oncology
media@olema.com
FAQ
When is Olema Pharmaceuticals (OLMA) presenting at the Jefferies Global Healthcare Conference 2025?
What time is OLMA's presentation at the Goldman Sachs Healthcare Conference 2025?
Where can I watch Olema Pharmaceuticals' (OLMA) investor conference presentations?
What type of company is Olema Pharmaceuticals (OLMA)?
